Multiple Clinical Trials Study The Benefits Of CBD For Easing COVID-19 Symptoms
Israeli scientists recently launched clinical trials to understand if cannabis can help deal with the coronavirus. Though lung health experts have warned smoking marijuana could exacerbate COVID-19 and its spread, Israeli scientists will study cannabidiol (CBD) alongside existing treatment options as a possible solution.
InnoCan Pharma and Tel Aviv University embarked on a collaboration to instill CBD medicine through exosomes which will target cell organs harmed by COVID-19. At this point, CBD’s anti-inflammatory properties are believed to help repair these cells via a synergistic effect. Earlier studies tell us that CBD can successfully regulate the body’s immune system and reduce inflammation.
A second clinical trial will occur over the coming weeks and includes 10 Covid-19 patients currently undergoing treatment in Israel’s Rabin Medical Center. Doctors will combine traditional steroids and CBD, with the belief CBD will enhance the therapeutic potential of the steroids.
This trial will have 40 patients. If it is successful, the study will expand to include more people. The third study was launched by Tel Aviv’s Ichilov Medical Center. They are studying the anti-inflammatory properties of CBD and the fact that it could potentially reduce respiratory symptoms experienced by most COVID-19 patients.
Read Full Article: https://www.benzinga.com
CBD is one of many powerful cannabinoids found in hemp known for helping to support our body and mind. Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. The FDA has not confirmed that CBD cures, treats, or prevents any diseases or conditions. Before reading this article please take a moment to read our full disclosure statement.